<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Frankfurt_Story"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Frankfurt/Story">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Frankfurt/Story&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Frankfurt/Story&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Frankfurt/Story&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Frankfurt/Story" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform">Â </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Frankfurt/Story</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><P><TITLE> Team: iGEM Frankfurt - 2012.igem.org </TITLE></P><DIV id="wrap"><DIV id="left"><UL id="menu"><LI><A href="https://2012.igem.org/Team:Frankfurt">Home</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Team">Team</A></LI><LI><A href="https://igem.org/Team.cgi?year=2012&amp;team_name=Frankfurt">Official Profile</A></LI></UL><LI><A href="https://2012.igem.org/Team:Frankfurt/Project">Project</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Organisms">Organisms</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/New_Yeast_RFC">Yeast RFC</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Parts">Parts</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Notebook">Notebook</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Notebook">Labwork</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Protocol">Protocols</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Safety">Safety</A></LI><LI><A>Human practices</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Ethics">Ethics</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Events">Events</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/BioSecurity">BioSecurity</A></LI><LI><A href="https://2012.igem.org/Team:Frankfurt/Attributions">Attributions</A></LI><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#DNA_constructs_for_realisation_of_our_idea"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">DNA constructs for realisation of our idea</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Mevalonate_Pathway_Overexpression"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Mevalonate Pathway Overexpression</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#Steviol_Production"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">Steviol Production</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#DNA_sources"><SPAN class="tocnumber">1.3</SPAN><SPAN class="toctext">DNA sources</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#Sequence_Editing"><SPAN class="tocnumber">1.4</SPAN><SPAN class="toctext">Sequence Editing</SPAN></A></LI></UL></TD></TR></TBODY></TABLE><H1><SPAN class="mw-headline" id="DNA_constructs_for_realisation_of_our_idea"><B> DNA constructs for realisation of our idea </B></SPAN></H1><H2><SPAN class="mw-headline" id="Mevalonate_Pathway_Overexpression">Mevalonate Pathway Overexpression</SPAN></H2><P>The vector for improving the MVA pathway flow contains three genes: A trunctated version of the HMG-CoA-Reductase, the native gene of the Farnesylpyrophosphate Synthase (ERG20) and the GGPP Synthase gene from <I>Sulfolobius acileratius</I>. The sources of the physical DNA were as following: </P><UL><LI><BIG> HMG-CoA-Reductase: </BIG> The sequence was obtained from the Saccharomyces Genome Database and modified. This version was send to a company for <I>de novo</I> synthesis.
</LI></UL><UL><LI><BIG> ERG20: </BIG> The gene was obtained from genomic DNA of the strain CEN.PK2. By using primers which contained overlaps with the pre- and suffix sequences it was amplified by PCR.
</LI></UL><UL><LI><BIG> GGPP-Synthase </BIG>: The sequence was obtained from the Pubmed Database and modified. This version was send to a company for <I>de novo</I> synthesis.
</LI></UL><P>construction of the insert:
pHXT7 <I>HMG-CoA</I> tHXT7  pPFK1 <I>ERG20</I> tPFK2 pPGK1 <I>GGPPS</I> tCYC1</P><P>plasmid backbone with <I>URA3</I></P><H2><SPAN class="mw-headline" id="Steviol_Production">Steviol Production</SPAN></H2><P>The vector for steviol production also contains three genes: The bifunctional cyclase from <I>Gibberella fujikuroi</I> (CPS/KS), the <I>ent</I>-kaurene oxidase from <I>Gibberella fujikuroi</I> (KO) and the <I>ent</I>-kaurenoic acid hydroxylase from <I>Stevia rebaudiana</I> (KAH). The sources of the physical DNA were as following: </P><UL><LI><BIG> bifunctional cyclase: </BIG> The sequence was obtained from the Pubmed Database and modified. This version was send to a company for <I>de novo</I> synthesis.
</LI></UL><UL><LI><BIG><I>ent</I>-kaurene oxidase: </BIG> The sequence was obtained from the Pubmed Database and modified. This version was send to a company for <I>de novo</I> synthesis (4 x 500 bp for Gibson Assembly).
</LI></UL><UL><LI><BIG><I>ent</I>-kaurenoic acid hydroxylase: </BIG> The sequence was obtained from the Pubmed Database and modified. This version was send to a company for <I>de novo</I> synthesis (4 x 500 bp for Gibson Assembly).
</LI></UL><P>construction of the insert:
pHXT7 <I>CPS/KS</I> tTAL1  pTPI1 <I>KO</I> tPDC1 pPGI1 <I>KAH</I> tCYC1</P><P>plasmid backbone with <I>HIS3</I></P><H2><SPAN class="mw-headline" id="DNA_sources">DNA sources</SPAN></H2><TABLE class="wikitable zebra"><TBODY><TR><TH>Templates</TH><TH>Amplified DNA Fragments
</TH></TR><TR><TD>synthesized sequence of <I>HMG-CoA</I></TD><TD><I>HMG-CoA</I></TD></TR><TR><TD>synthesized sequence of <I>GGPPS</I></TD><TD><I>GGPPS</I></TD></TR><TR><TD>chromosomal DNA of CEN.PK2-1C</TD><TD><I>ERG20</I></TD></TR><TR><TD>synthesized sequence of <I>Cps/Ks</I></TD><TD><I>CPS/KS</I></TD></TR><TR><TD>synthesized sequence of <I>KO</I></TD><TD><I>ent</I>-kaurene oxidase
</TD></TR><TR><TD>synthesized sequence of <I>KAH</I></TD><TD><I>ent</I>-kaurenoic acid hydroxylase
</TD></TR><TR><TD>pUD8e (yeast shuttle plasmid)</TD><TD>pPFK1, pTPI1, tHXT7, tTAL1
</TD></TR><TR><TD>pUD22e (yeast shuttle plasmid)</TD><TD>pPGK1, pPGI1, tPFK2, tPDC1
</TD></TR></TBODY></TABLE><H2><SPAN class="mw-headline" id="Sequence_Editing">Sequence Editing</SPAN></H2><P>The most of our genes were synthesized, because they contained several biobrick restriction sites. The relevant codons were replaced by different codons which encode for the same amino acid. Only <I>ERG20</I> has no biobrick restriction sites.</P><UL><LI><I>HMG-CoA</I></LI></UL><P>synthesized sequence 
5`: 45 bp overlap to pHXT7 and the prefix
3`: the suffix and 33 bp overlap to tHXT7</P><UL><LI><I>ERG20</I></LI></UL><P>gene from chromosomal DNA of CEN.PK2-1C
5`: 16 bp overlap to pPFK1 and the prefix (added via primer)
3`: the suffix and 14 bp overlap to tPFK2 (added via primer)</P><UL><LI><I>GGPPS</I></LI></UL><P>synthesized sequence
5`: 18 bp overlap to pPGK1 and the prefix
3`: the suffix and 45 bp overlap to tCYC1</P><UL><LI><I>CPS/KS</I></LI></UL><P>synthesized sequence
5': 45 bp overlap to PHXT7 and the prefix
3': the suffix and 17 bp overlap to tTAL1</P><UL><LI><I>KO</I></LI></UL><P>synthesized sequence (4 x 500 bp for Gibson Assembly)
5': 15 bp overlap to pTPI1 and the prefix
3': the suffix and 16 bp overlap to tPDC1</P><UL><LI><I>KAH</I></LI></UL><P>synthesized sequence (4 x 500 bp for Gibson Assembly)
5': 15 bp overlap to pPGI1 and the prefix
3': the suffix and 45 bp overlap to tCYC1</P><UL><LI>promoters and terminators</LI></UL><P>They were amplified from plasmids via PCR with designed primers. 
The primer contain about 20 to 30 bp of the promoter or terminator sequence for PCR and about 30 bp overlap to the neighbouring sequence for homologue recombination.
</P><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Frankfurt/Story">http://2012.igem.org/Team:Frankfurt/Story</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Frankfurt/Story" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Frankfurt/Story" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Frankfurt/Story&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Frankfurt/Story&amp;oldid=195922" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></DIV></BODY></HTML>